Literature DB >> 23732308

Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan.

Te-Pin Chang1, Mao-Wang Ho, Yun-Liang Yang, Pai-Chang Lo, Pei-Sheng Lin, An-Huei Wang, Hsiu-Jung Lo.   

Abstract

Invasive fungal infections have increased significantly in the past few decades because of the increase in high-risk populations. To investigate the distribution and drug susceptibilities of such infections, we analyzed all 152 Candida isolates causing candidemia from 2004 to 2006 at the China Medical University Hospital, a medical center in central Taiwan. Candida albicans was the most common species, accounting for 52.6% of the isolates, followed by C. tropicalis (19.7%), C. parapsilosis (14.5%), C. glabrata (8.6%), C. guilliermondii (3.9%), and C. pelliculosa (0.7%). All isolates were susceptible to amphotericin B, anidulafungin, micafungin, and voriconazole according to minimum inhibitory concentrations (MICs) after a 24-h incubation; 0.7%, 6.6%, and 7.9% of isolates were resistant to amphotericin B, fluconazole, and voriconazole, respectively, after 48-h incubation. Both C. albicans and C. parapsilosis had high degrees of agreement for azoles between 24- and 48-h incubation periods, whereas C. glabrata (38.5-46.2%) and C. tropicalis (56.7-63.3%) did not. The majority of the isolates with high azole MICs displayed a trailing growth phenotype. Hence, the MICs of different drugs after 24-h incubation may be considered for prognosis of candidemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732308     DOI: 10.1007/s10156-013-0623-8

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  11 in total

1.  Development of two molecular approaches for differentiation of clinically relevant yeast species closely related to Candida guilliermondii and Candida famata.

Authors:  Xiaobo Feng; Jingsong Wu; Bo Ling; Xianwei Yang; Wanqing Liao; Weihua Pan; Zhirong Yao
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

2.  Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis.

Authors:  Ying-Lien Chen; Shang-Jie Yu; Hsin-Yu Huang; Ya-Lin Chang; Virginia N Lehman; Fitz Gerald S Silao; Ursela G Bigol; Alice Alma C Bungay; Anna Averette; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2014-01-17

3.  Candidemia due to Candida guilliermondii in an immuno-compromised infant: a case report and review of literature.

Authors:  Fatemeh Ahangarkani; Hamid Badali; Mohammad Sadegh Rezai; Tahereh Shokohi; Zahra Abtahian; Hassan Mahmoodi Nesheli; Hossein Karami; Emmanuel Roilides; Ahmad Tamaddoni
Journal:  Curr Med Mycol       Date:  2019-03

4.  The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression.

Authors:  Célia F Rodrigues; Bruna Gonçalves; Maria Elisa Rodrigues; Sónia Silva; Joana Azeredo; Mariana Henriques
Journal:  Mycopathologia       Date:  2017-04-24       Impact factor: 2.574

5.  Effects of human blood red cells on the haemolytic capability of clinical isolates of Candida tropicalis.

Authors:  Marcia Cristina Furlaneto; Daniel Favero; Emanuele Julio Galvão França; Luciana Furlaneto-Maia
Journal:  J Biomed Sci       Date:  2015-02-11       Impact factor: 8.410

6.  Evaluation of Virulence Factors In vitro, Resistance to Osmotic Stress and Antifungal Susceptibility of Candida tropicalis Isolated from the Coastal Environment of Northeast Brazil.

Authors:  Diana L Zuza-Alves; Sayama S T Q de Medeiros; Luanda B F C de Souza; Walicyranison P Silva-Rocha; Elaine C Francisco; Maria C B de Araújo; Reginaldo G Lima-Neto; Rejane P Neves; Analy S de Azevedo Melo; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2016-11-15       Impact factor: 5.640

Review 7.  An Update on Candida tropicalis Based on Basic and Clinical Approaches.

Authors:  Diana L Zuza-Alves; Walicyranison P Silva-Rocha; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2017-10-13       Impact factor: 5.640

8.  Studying the Prevalence, Species Distribution, and Detection of In vitro Production of Phospholipase from Candida Isolated from Cases of Invasive Candidiasis.

Authors:  Yukti Sharma; Susheel Kumar Chumber; Mandeep Kaur
Journal:  J Glob Infect Dis       Date:  2017 Jan-Mar

9.  Evaluation of Biofilm Formation in Candida tropicalis Using a Silicone-Based Platform with Synthetic Urine Medium.

Authors:  Yi-Kai Tseng; Yu-Chia Chen; Chien-Jui Hou; Fu-Sheng Deng; Shen-Huan Liang; Sin Yong Hoo; Chih-Chieh Hsu; Cai-Ling Ke; Ching-Hsuan Lin
Journal:  Microorganisms       Date:  2020-05-01

Review 10.  Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Authors:  Patrick Van Dijck; Jelmer Sjollema; Bruno P Cammue; Katrien Lagrou; Judith Berman; Christophe d'Enfert; David R Andes; Maiken C Arendrup; Axel A Brakhage; Richard Calderone; Emilia Cantón; Tom Coenye; Paul Cos; Leah E Cowen; Mira Edgerton; Ana Espinel-Ingroff; Scott G Filler; Mahmoud Ghannoum; Neil A R Gow; Hubertus Haas; Mary Ann Jabra-Rizk; Elizabeth M Johnson; Shawn R Lockhart; Jose L Lopez-Ribot; Johan Maertens; Carol A Munro; Jeniel E Nett; Clarissa J Nobile; Michael A Pfaller; Gordon Ramage; Dominique Sanglard; Maurizio Sanguinetti; Isabel Spriet; Paul E Verweij; Adilia Warris; Joost Wauters; Michael R Yeaman; Sebastian A J Zaat; Karin Thevissen
Journal:  Microb Cell       Date:  2018-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.